|
BMPR2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.07329999729811E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.33210000200046E-08 |
| Normal-vs-Stage2 |
3.410200E-04 |
| Normal-vs-Stage3 |
1.713630E-02 |
| Normal-vs-Stage4 |
3.808000E-02 |
| Stage1-vs-Stage2 |
7.404600E-01 |
| Stage1-vs-Stage3 |
2.222000E-01 |
| Stage1-vs-Stage4 |
8.749000E-01 |
| Stage2-vs-Stage3 |
5.158800E-01 |
| Stage2-vs-Stage4 |
9.349200E-01 |
| Stage3-vs-Stage4 |
5.804000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.30869999784389E-08 |
| Normal-vs-AfricanAmerican |
3.71169999999754E-05 |
| Normal-vs-Asian |
3.567000E-04 |
| Caucasian-vs-AfricanAmerican |
6.522400E-01 |
| Caucasian-vs-Asian |
3.369600E-01 |
| AfricanAmerican-vs-Asian |
5.219200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.46169981568778E-10 |
| Normal-vs-Female |
8.880400E-02 |
| Male-vs-Female |
2.551700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.76620000000139E-05 |
| Normal-vs-Extreme_Weight |
1.14380005467041E-09 |
| Normal-vs-Obese |
5.995900E-04 |
| Normal-vs-Extreme_Obese |
5.94179999999778E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.064600E-01 |
| Normal_Weight-vs-Obese |
3.395600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.279800E-01 |
| Extreme_Weight-vs-Obese |
3.549700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.503800E-01 |
| Obese-vs-Extreme_Obese |
2.902400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.097200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.389840E-04 |
| Normal-vs-Age(61-80Yrs) |
2.02659999892774E-10 |
| Normal-vs-Age(81-100Yrs) |
5.58489999999967E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.428200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.784300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.383840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.261600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.194400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.940400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.54840000213363E-08 |
| Normal-VS-Type2 PRCC |
8.55670001520537E-09 |
| Normal-VS-KIRP CIMP |
7.986000E-01 |
| Normal-VS-Unclassified PRCC |
5.928200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.360610E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.740200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.006100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.295900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.538300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.142600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.40710024030011E-10 |
| Normal-vs-N1 |
9.689600E-02 |
| Normal-vs-N2 |
2.036600E-01 |
| N0-vs-N1 |
3.469900E-02 |
| N0-vs-N2 |
9.399700E-02 |
| N1-vs-N2 |
9.420800E-01 |
|
|
